A traditional Chinese medicine composition for treating porcine reproductive and respiratory syndrome (PRRS) and its application.
The treatment of porcine reproductive and respiratory syndrome (PRRS) using a specially formulated combination of traditional Chinese medicines has overcome the shortcomings of existing preparations in symptom relief and growth performance improvement, achieving significant improvement in clinical symptoms and enhanced immunity.
Patent Information
- Application Number
- CN202211723254.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-30
- Publication Date
- 2026-01-30
- Estimated Expiration
- 2042-12-30
AI Technical Summary
Existing traditional Chinese medicine preparations lack significant efficacy in treating symptoms such as fever, cough, and wheezing in porcine reproductive and respiratory syndrome (PRRS), and have failed to significantly improve the growth performance and immune resistance of affected pigs.
It is prepared as a drug preparation or feed additive by combining Chinese herbal medicines such as Scutellaria baicalensis, Anemarrhena asphodeloides, Rheum palmatum, Gypsum fibrosum, Houttuynia cordata, Mentha haplocalyx, Atractylodes lancea, Citrus reticulata peel, Poria cocos, Magnolia officinalis, Pueraria lobata, Ligustrum lucidum, Ephedra sinica, Prunus armeniaca, Gynostemma pentaphyllum, Astragalus membranaceus, Psoralea corylifolia, and Glycyrrhiza uralensis. It is administered by drinking water or mixing with feed and has the effects of clearing heat and detoxifying, relieving cough and promoting rash eruption, strengthening the spleen and clearing the lungs, drying dampness and promoting yang, and regulating the body's immune response.
It significantly alleviates symptoms such as fever and coughing caused by porcine reproductive and respiratory syndrome (PRRS), improves growth performance, reduces inflammatory response, enhances immune defense, and does not induce antibiotic resistance.